Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Oramed Pharmaceuticals Inc

OJU1
Current price
2.13 EUR 0 EUR (0.00%)
Last closed 2.34 USD
ISIN US68403P2039
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 94 584 080 USD
Yield for 12 month +13.17 %
1Y
3Y
5Y
10Y
15Y
OJU1
21.11.2021 - 28.11.2021

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides. The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes. It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York. Address: 1185 Avenue of the Americas, New York, NY, United States, 10036

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.25 USD

P/E ratio

4.549

Dividend Yield

Current Year

+1 340 000 USD

Last Year

+2 703 000 USD

Current Quarter

Last Quarter

Current Year

Last Year

+2 703 000 USD

Current Quarter

Last Quarter

Key Figures OJU1

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 650 000 USD
Operating Margin TTM
PE Ratio 4.549
Return On Assets TTM -4.72 %
PEG Ratio
Return On Equity TTM 12.7 %
Wall Street Target Price 3.25 USD
Revenue TTM
Book Value 4.06 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 2 703 000 USD
Earnings per share 0.51 USD
Diluted Eps TTM 0.51 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics OJU1

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History OJU1

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:12
Payout Ratio
Last Split Date 23.01.2013
Dividend Date

Stock Valuation OJU1

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 4.549
Forward PE
Enterprise Value Revenue 2.8649
Price Sales TTM 141.5422
Enterprise Value EBITDA 0.5244
Price Book MRQ 0.5319

Financials OJU1

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OJU1

For 52 weeks

1.99 USD 3.67 USD
50 Day MA 2.38 USD
Shares Short Prior Month 340 413
200 Day MA 2.53 USD
Short Ratio 3.37
Shares Short 298 473
Short Percent 0.81 %